Stocks will have less room to run this year as major tech names struggle, according to Goldman Sachs.
Related Posts
GLP-1s can help employers lower medical costs in 2 years, new study finds
As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.
Morgan Stanley says Fed won’t cut rates until next year because of tariff impact on inflation
Tariffs are likely to spur inflation before slowing growth, the investment bank said.
A stock market hedge if this comeback is a head fake and bigger losses are ahead
Tony Zhang details a spread trade in the SPDR S&P 500 Trust.